Casagrande N, Borghese C, Aldinucci D. In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability. haematol [Internet]. 2022Jan.1 [cited 2024Dec.26];107(1):287-91. Available from: https://haematologica.org/article/view/haematol.2021.279389